market sentiment vs trial results

Well, after announcing excellent results last Friday for an extended suite of markers for the OvPlex test, Healthlink's SP enjoyed a brief ride upwards followed by a decline late Friday and throughout today, back to pre-announcement levels - closing price today of $0.082.

Clearly the market remains underwhelmed by the sales prospects for OvPlex, and a lot of holders took this opportunity to leave the stock.

Last Friday's trial results were good: no question, and the notion that these markers can (which I assume) be integrated into an existing product means that if anything is capable of revving up OvPlex as a sellable product, extending the bio-markers in accordance with the recent tests will do it.

In my assessment, all the pieces are in place, and Mr Market's recalcitrance will be only temporary.
So I hold.

Topped up today in the low 0.080's. Somehow I don't think we'll see the stock sold at these prices for long.

P.